120 related articles for article (PubMed ID: 16530511)
21. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
22. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
23. Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation.
Alonso O; Loinaz C; Moreno E; Jiménez C; Abradelo M; Gómez R; Meneu JC; Lumbreras C; García I
Transpl Int; 2005 Aug; 18(8):902-7. PubMed ID: 16008738
[TBL] [Abstract][Full Text] [Related]
24. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
[TBL] [Abstract][Full Text] [Related]
25. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis.
Morioka D; Egawa H; Kasahara M; Jo T; Sakamoto S; Ogura Y; Haga H; Takada Y; Shimada H; Tanaka K
Liver Transpl; 2007 Jan; 13(1):80-90. PubMed ID: 16964594
[TBL] [Abstract][Full Text] [Related]
26. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
[TBL] [Abstract][Full Text] [Related]
27. DR antigens influence graft outcome and HCV recurrence after liver transplantation.
Kimball P; Stravitz T
Transplant Proc; 2005 Mar; 37(2):1099-100. PubMed ID: 15848634
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
29. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
[TBL] [Abstract][Full Text] [Related]
30. Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
Vivarelli M; Burra P; La Barba G; Canova D; Senzolo M; Cucchetti A; D'Errico A; Guido M; Merenda R; Neri D; Zanello M; Giannini FM; Grazi GL; Cillo U; Pinna AD
J Hepatol; 2007 Dec; 47(6):793-8. PubMed ID: 17928091
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
32. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
Ho VT; Kim HT; Liney D; Milford E; Gribben J; Cutler C; Lee SJ; Antin JH; Soiffer RJ; Alyea EP
Bone Marrow Transplant; 2006 May; 37(9):845-50. PubMed ID: 16532020
[TBL] [Abstract][Full Text] [Related]
33. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
34. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
35. Host and donor risk factors before and after liver transplantation that impact HCV recurrence.
Berenguer M
Liver Transpl; 2003 Nov; 9(11):S44-7. PubMed ID: 14586894
[TBL] [Abstract][Full Text] [Related]
36. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
[TBL] [Abstract][Full Text] [Related]
37. Recurrent autoimmune hepatitis after orthotopic liver transplantation.
González-Koch A; Czaja AJ; Carpenter HA; Roberts SK; Charlton MR; Porayko MK; Rosen CB; Wiesner RH
Liver Transpl; 2001 Apr; 7(4):302-10. PubMed ID: 11303289
[TBL] [Abstract][Full Text] [Related]
38. DRB1 alleles in relation to severity of liver disease in patients with chronic hepatitis C.
Kryczka W; Brojer E; Kalińska A; Urbaniak A; Zarebska-Michaluk D
Med Sci Monit; 2001 May; 7 Suppl 1():217-20. PubMed ID: 12211723
[TBL] [Abstract][Full Text] [Related]
39. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
40. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
